Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation-Reference-Cited by-同舟云学术

Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation

Published:2020-02 Issue:9 Volume:38 Page:2229-2240
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Angelidou Asimenia,Conti Maria-Giulia,Diray-Arce Joann,Benn Christine S.^ORCID,Shann Frank,Netea Mihai G.,Liu Mark,Potluri Lakshmi Prasad,Sanchez-Schmitz Guzman,Husson Robert,Ozonoff Al,Kampmann Beate,van Haren Simon Daniël,Levy Ofer

Funder

National Institute of Allergy and Infectious Diseases

Human Immunology Project Consortium

American Academy of Pediatrics

Sapienza University

Danish National Research Foundation

Netherlands Organization for Scientific Research

UK Research and Innovation

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference53 articles.

1. UNICEF. BCG vaccine: current supply & demand outlook; 2015.

2. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness;Trunz;Lancet,2006

3. Tuberculosis susceptibility and protection in children;Basu Roy;Lancet Infect Dis,2019

4. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review;Higgins;BMJ,2016

5. Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial;Biering-Sorensen;Clin Infect Dis,2017

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases;iScience;2024-06

2. BCG vaccination is associated with longitudinal changes in systemic eicosanoid levels in elderly individuals: A secondary outcome analysis;Heliyon;2024-06

3. Cyclodextrin microneedles for the delivery of a nanoparticle-based peptide antigen vaccine;European Journal of Pharmaceutics and Biopharmaceutics;2024-05

4. Effects of Neonatal BCG-Japan Versus BCG-Russia Vaccination on Overall Mortality and Morbidity: Randomized Controlled Trial From Guinea-Bissau (BCGSTRAIN II);Open Forum Infectious Diseases;2024-02-01

5. Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?;Human Vaccines & Immunotherapeutics;2024-01-29